在IVA阶段的胸膜瘤中进行高热性胸内化疗 (HITHOC):叙述性综述
Paolo Mendogni1, Riccardo Orlandi2, Marcello Ambrogi3
1Thoracic Surgery and Lung Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Mediastinum (Hong Kong, China)
|July 16, 2025
概括
超热胸内化疗 (HITHOC) 与手术相结合,为患有多发性扩散的晚期胸腺瘤提供了一种有前途的新方法. 这种技术改善了局部控制,并可能减少复发率在具有挑战性的情况下.
科学领域:
- 胸部瘤学 胸部瘤学
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 手术是胸腺瘤的主要治疗方法,但在控制传播疾病或复发方面存在局限性.
- 目前针对晚期胸腺瘤的多学科治疗方法,包括化疗和放射治疗,显示出不满意的疗效,缺乏标准化.
- 先进的胸腺瘤,特别是IVA阶段的胸腺瘤和胸膜扩散或复发的胸腺瘤,存在重大管理挑战.
研究的目的:
- 审查超热胸内化疗 (HITHOC) 的机制,指示,程序方面和治疗结果,以管理多叶膜瘤的多叶膜瘤.
- 评价HITHOC作为高级胸腺瘤和与胸腺瘤相关的多叶膜复发的细胞还原手术的辅助.
- 探索HITHOC在胸部瘤学的未来潜力.
主要方法:
- 使用MEDLINE和谷歌学者进行了全面的文献搜索.
- 包括的研究包括原始全篇文章,元分析,综述文章和案例报告.
- 文献搜索仅限于到2025年1月的出版物.
主要成果:
- 超热性胸内化疗 (HITHOC) 是宏观激进性肺部瘤切除的辅助方法.
- HITHOC可以增强晚期胸腺瘤的局部瘤控制.
- 这种技术已经证明有潜力降低高级胸腺瘤的复发率.
结论:
- HITHOC,结合细胞还原性手术,是一种有前途的策略,用于晚期胸腺瘤与膜扩散.
- 这种方法可以克服传统疗法的局限性,改善局部疾病控制和生存率.
- 在现代多式模式的治疗策略中,HITHOC代表了一个潜在的关键组成部分.
相关概念视频
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664